Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 1/2 6Phase 2 5Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Follicular 15Lymphoma 15Multiple Myeloma 14Lymphoma, Mantle-Cell 14Leukemia, Myeloid, Acute 14Leukemia, Lymphocytic, Chronic, B-Cell 14Lymphoma, Non-Hodgkin 13Leukemia 13Hodgkin Disease 13Congenital Abnormalities 13Burkitt Lymphoma 13Lymphoma, Large B-Cell, Diffuse 12Lymphoma, B-Cell, Marginal Zone 12Leukemia, Myeloid, Chronic-Phase 12Lymphoma, Large-Cell, Immunoblastic 11Leukemia, Myeloid, Accelerated Phase 11Myeloproliferative Disorders 10Myelodysplastic Syndromes 10Recurrence 9Primary Myelofibrosis 9Lymphoma, T-Cell, Cutaneous 9Dendritic Cell Sarcoma, Interdigitating 9Blast Crisis 8Sezary Syndrome 7Mycosis Fungoides 7Leukemia, Myelomonocytic, Chronic 7Anemia, Refractory, with Excess of Blasts 7Waldenstrom Macroglobulinemia 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

fludarabine 2Cyclophosphamide 2zanubrutinib 1pegfilgrastim 1obinutuzumab 1fludarabine phosphate 1Specimen Handling 1Resistance Training 1Radiotherapy 1Neuropsychological Tests 1Modafinil 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Injections 1Filgrastim 1Contrast Media 1Blood Specimen Collection 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, B-Cell × fludarabine phosphate × Clear all
NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

The First Affiliated Hospital of Soochow University

Phase NA Unknown
20 enrolled
Lymphoid

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡